JPS6043341B2 - carbostyril derivatives - Google Patents
carbostyril derivativesInfo
- Publication number
- JPS6043341B2 JPS6043341B2 JP9353377A JP9353377A JPS6043341B2 JP S6043341 B2 JPS6043341 B2 JP S6043341B2 JP 9353377 A JP9353377 A JP 9353377A JP 9353377 A JP9353377 A JP 9353377A JP S6043341 B2 JPS6043341 B2 JP S6043341B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- compound
- general formula
- acid
- dihydrocarbostyryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 125000005606 carbostyryl group Chemical group 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- -1 3-pyridylmethyl Chemical group 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000007514 bases Chemical class 0.000 description 4
- 125000004076 pyridyl group Chemical group 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VYGSFTVYZHNGBU-UHFFFAOYSA-N trichloromethanesulfonic acid Chemical compound OS(=O)(=O)C(Cl)(Cl)Cl VYGSFTVYZHNGBU-UHFFFAOYSA-N 0.000 description 1
- DGCFCIXSJPYNLX-UHFFFAOYSA-N trichloromethylsulfonyl trichloromethanesulfonate Chemical compound ClC(Cl)(Cl)S(=O)(=O)OS(=O)(=O)C(Cl)(Cl)Cl DGCFCIXSJPYNLX-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】 本発明は新規なりルボスチリル誘導体に関する。[Detailed description of the invention] The present invention relates to novel rubostyril derivatives.
本発明の化合物は新規化合物であつて、一般式 、 〔
I〕
〔式中Rは水素原子、低級アルキル基又はピリジルアル
キル基を、カルボスチリル骨格の3.4位の結合は一重
結合又は二重結合を夫々示す。The compound of the present invention is a new compound, and has the general formula: [
I] [In the formula, R represents a hydrogen atom, a lower alkyl group, or a pyridyl alkyl group, and the bond at the 3.4-position of the carbostyryl skeleton represents a single bond or a double bond, respectively.
〕で表わされる。該化合物は消炎作用、血小板凝集抑制
作用、抗菌作用及び血液中の脂質含有量特にコレステロ
ール、ホスホリピド、トリグリセリド等の含有量を低下
させる作用を有し、消炎剤、血栓予防剤、抗菌剤、動脈
硬化症の治療及ひ予防薬等として有用である。上記一般
式〔I〕に於て、Rで示される低級アルキル基としては
炭素数1〜4の直鎖もしくは分枝状アルキル基を挙げる
ことができ、具体的にはメチル、エチル、プロピル、イ
ソプロピル、ブチル、sec−ブチル基等を例示でき、
またピリジルアルキル基としては炭素数1〜4の直鎖も
しくは分枝状のアルキレン基とピリジル基とが結合した
基を挙げることができ、具体的には3−ピリジルメチル
、2−(ピリジンー3−イル)エチル、3−(ピリジン
ー4−イル)プロピル、1・1−ジメチルー2−(ピリ
ジンー3−イル)エチル、2−メチルー3−(ピリジン
ー2−イル)プロピル、4−(ピリジンー2−イル)ブ
チル基等を例示できる。]. The compound has anti-inflammatory effects, platelet aggregation inhibitory effects, anti-bacterial effects, and the effect of lowering the lipid content in the blood, especially cholesterol, phospholipids, triglycerides, etc., and is effective as an anti-inflammatory agent, antithrombotic agent, antibacterial agent, and arteriosclerosis agent. It is useful as a treatment and prophylaxis for diseases. In the above general formula [I], the lower alkyl group represented by R may be a straight chain or branched alkyl group having 1 to 4 carbon atoms, specifically methyl, ethyl, propyl, isopropyl. , butyl, sec-butyl groups, etc.
Examples of the pyridyl alkyl group include groups in which a linear or branched alkylene group having 1 to 4 carbon atoms is bonded to a pyridyl group, specifically 3-pyridylmethyl, 2-(pyridine-3- yl)ethyl, 3-(pyridin-4-yl)propyl, 1,1-dimethyl-2-(pyridin-3-yl)ethyl, 2-methyl-3-(pyridin-2-yl)propyl, 4-(pyridin-2-yl) An example is a butyl group.
本発明化合物のうち代表的なものを以下に掲げる。Representative compounds of the present invention are listed below.
06−カルボキシー 3.4−ジヒドロカルボスチリル
06−カルボキシカルボスチリル○6−エトキシカルボ
ニルー3●4−ジヒドロカルボスチリル○6−エトキシ
カルボニルカルボスチリル06−(3−ピリジルメトキ
シカルボニル)−3・4−ジヒドロカルボスチリル06
−(3−ピリジルメトキシカルボニル)カルボスチリル
06−(Sec−ブトキシカルボニル)−3●4−ジヒ
ドロカルボスチリル○6−イソプロポキシカルボニルカ
ルボスチリル○6−ブトキシカルボニルー3●4−ジヒ
ドロカルボスチリル06−〔2(ピリジンー3−イル)
エトキシカルボニル〕−3●4−ジヒドロカルボスチリ
ル06−〔2−メチルー3−(ピリジンー2−イル)プ
ロポキシカルボニル〕カルボスチリル06−〔3−(ピ
リジンー4−イル)プロポキシカルボニル〕−3●4−
ジヒドロカルボスチリノレ06−〔1●1−ジメチルー
2−(ピリジンー3ーイル)エトキシカルボニル〕一カ
ルボスチリZノレ上記一般式〔1〕で表わされる本発明
の化合物は種々の方法により製造されるが、例えば下式
に示す如くして製造される。06-carboxy 3.4-dihydrocarbostyryl 06-carboxycarbostyryl○6-ethoxycarbonyl-3●4-dihydrocarbostyryl○6-ethoxycarbonylcarbostyryl06-(3-pyridylmethoxycarbonyl)-3,4-dihydro Calbostyril 06
-(3-pyridylmethoxycarbonyl)carbostyryl 06-(Sec-butoxycarbonyl)-3●4-dihydrocarbostyryl○6-isopropoxycarbonylcarbostyryl○6-butoxycarbonyl-3●4-dihydrocarbostyryl06-[ 2 (pyridin-3-yl)
Ethoxycarbonyl]-3●4-dihydrocarbostyryl 06-[2-methyl-3-(pyridin-2-yl)propoxycarbonyl]carbostyryl 06-[3-(pyridin-4-yl)propoxycarbonyl]-3●4-
Dihydrocarbostyrinore 06-[1●1-dimethyl-2-(pyridin-3-yl)ethoxycarbonyl]-carbostyrinore Z The compound of the present invention represented by the above general formula [1] can be produced by various methods, For example, it is manufactured as shown in the following formula.
(上記に於てXはハロゲン原子を示す。(In the above, X represents a halogen atom.
)即ち一般式〔■〕で表わされる公知のアセチルカルボ
スチリル誘導体とハロゲンとを反応させて一般式〔■〕
で表わされるα−ジハロゲノアセチルカルボスチリル誘
導体を得、次いでこれに塩基性化合物を反応させて本発
明の一般式〔1−1〕で表わされるカルボスチリル誘導
体が製造される。) That is, a known acetylcarbostyryl derivative represented by the general formula [■] and a halogen are reacted to form the general formula [■]
An α-dihalogenoacetylcarbostyryl derivative represented by is obtained, and then a basic compound is reacted with the α-dihalogenoacetylcarbostyryl derivative to produce a carbostyryl derivative represented by the general formula [1-1] of the present invention.
また一般式〔1−1〕の化合物をエステル化して下記一
般式〔1−2〕で表わされるカルボスチリル誘導体が製
造される。〔式中R″は低級アルキル基又はピリジルア
ルキル基〕一般式〔■〕の化合物とハロゲンとの配合割
合は特に限定されず広い範囲内で適宜選択されるが、通
常前者に対して後者を2〜5倍モル、好ましくは2〜3
倍モル量用いるのがよい。Further, a carbostyryl derivative represented by the following general formula [1-2] is produced by esterifying the compound of general formula [1-1]. [In the formula, R'' is a lower alkyl group or a pyridyl alkyl group] The compounding ratio of the compound of the general formula [■] and the halogen is not particularly limited and is appropriately selected within a wide range, but usually the latter is 2 to 2 of the former. ~5 times molar, preferably 2-3
It is better to use twice the molar amount.
一般式〔■〕の化合物とハロゲンとの反応は通常溶媒中
で行なわれる。用いられる溶媒としてはテトラヒドロフ
ラン、ジオキサン等のエーテル類、酢酸、プロピオン酸
等のカルボン酸類、ベンゼン等の芳香族炭化水素、ジメ
チルホルムアミド、ジメチルスルホキシド等を例示でき
る。該反応に於ては副生するハロゲン化水素を除去する
ために脱酸剤として炭酸カルシウム等を添加してもよい
。該反応は通常0〜50℃で行なうのがよく、通常数時
間〜2麟間程度で反応終了する。一般式〔■〕の化合物
から一般式〔1−1〕の化合物を得る反応は塩基性化合
物の存在下水溶液中にて行なうのがよい。The reaction between the compound of general formula [■] and a halogen is usually carried out in a solvent. Examples of the solvent used include ethers such as tetrahydrofuran and dioxane, carboxylic acids such as acetic acid and propionic acid, aromatic hydrocarbons such as benzene, dimethylformamide, and dimethylsulfoxide. In this reaction, calcium carbonate or the like may be added as a deoxidizing agent to remove by-produced hydrogen halide. The reaction is usually carried out at a temperature of 0 to 50°C, and is usually completed within several hours to about 2 minutes. The reaction for obtaining the compound of general formula [1-1] from the compound of general formula [■] is preferably carried out in an aqueous solution in the presence of a basic compound.
塩基性化合物としては公知のものを広く使用でき、例え
は水酸化ナトリウム、水酸化カリウム、水酸化カルシウ
ム等のアルカリ金属水酸化物もしくはアルカリ土類金属
水酸化物等を挙げることができる。塩基性化合物の使用
量としては特に限定されず広い範囲内で選択されるが、
一般には一般式〔■〕の化合物に対して2倍モル〜大過
剰量使用するのがよい。該反応は通常50〜150℃、
好ましくは70〜120℃で行なうのがよく、通常1〜
1満間程度で反応は終了する。一般式〔1−1〕で表わ
される化合物と一般式〔式中R″は前記に同じ〕で表わ
されるアルコール類とのエステル化反応は、通常のエス
テル化反応の条件下で行なわれる。上記反応は通常触媒
の存在下に行なわれる。触媒としてはエステル化反応に
慣用の触媒がいずれも用いられる。その具体例としては
、塩酸ガス、濃硫酸、リン酸、ポリリン酸、三フッ化ホ
ウ素、過塩素酸などの無機酸、トリフルオロ酢酸、トリ
クロロメタンスルホン酸、ナフタレンスルホン酸、p−
トシル酸、ベンゼンスルホン酸、エタンスルホン酸など
の有機酸、トリクロロメタンスルホン酸無水物、トリフ
ルオロメタンスルホン酸無水物などの酸無水物、塩化チ
オニル、アセトン、ジメチルアセタールなどが挙げられ
る。また酸性イオン交換樹脂も用いられる。また上記反
応は無溶媒もしくは溶媒の存在下で実施される。溶媒と
してはエステル化反応に慣用の溶媒が用いられる。その
具体例としては、ベンゼン、トルエン、キシレンなどの
芳香族炭化水素類、ジクロロメタン、ジクロロエタン、
クロロホルム、四塩化炭素などのハロゲン化炭化水素類
、ジエチルエーテル、テトラヒドロフラン、ジオキサン
、エチレングリコールモノメチルエーテルなどのエーテ
ル類などが挙げられる。更に上記反応は無水塩化カルシ
ウム、無水硫酸銅、油水硫酸カルシウム、五酸化リンな
どの乾燥剤の使用により有利に行われる。上記エステル
化反応において一般式〔1−1〕および〔■〕で表わさ
れる化合物の使用割合は、特に限定されず適宜に選択で
きるが、無溶媒の場合は前者に対して後者を大過剰用い
、溶媒を使用する場合は、前者に対して後者を等モル〜
5倍モル、好ましくは等モル〜2倍モル量程度用いるが
望ましい。反応温度は特に限定されないが、通常−20
〜200℃程度、好ましくは0〜150℃程度を採用で
きる。以上のようにして一般式〔1−2〕で表わされる
本発明化合物が製造される。As the basic compound, a wide variety of known compounds can be used, such as alkali metal hydroxides or alkaline earth metal hydroxides such as sodium hydroxide, potassium hydroxide, and calcium hydroxide. The amount of the basic compound used is not particularly limited and can be selected within a wide range,
Generally, it is preferable to use the compound in an amount ranging from 2 times the mole to a large excess amount relative to the compound of the general formula [■]. The reaction is usually carried out at 50 to 150°C,
Preferably, the temperature is 70 to 120°C, and usually 1 to 120°C.
The reaction completes in about 1 full hour. The esterification reaction between the compound represented by the general formula [1-1] and the alcohol represented by the general formula [in the formula, R'' is the same as above] is carried out under normal esterification reaction conditions.The above reaction This is usually carried out in the presence of a catalyst. Any catalyst commonly used for esterification reactions can be used. Specific examples include hydrochloric acid gas, concentrated sulfuric acid, phosphoric acid, polyphosphoric acid, boron trifluoride, Inorganic acids such as chloric acid, trifluoroacetic acid, trichloromethanesulfonic acid, naphthalenesulfonic acid, p-
Examples include organic acids such as tosylic acid, benzenesulfonic acid and ethanesulfonic acid, acid anhydrides such as trichloromethanesulfonic anhydride and trifluoromethanesulfonic anhydride, thionyl chloride, acetone, and dimethyl acetal. Acidic ion exchange resins are also used. Further, the above reaction is carried out without a solvent or in the presence of a solvent. As the solvent, a solvent commonly used in esterification reactions is used. Specific examples include aromatic hydrocarbons such as benzene, toluene, and xylene, dichloromethane, dichloroethane,
Examples include halogenated hydrocarbons such as chloroform and carbon tetrachloride, and ethers such as diethyl ether, tetrahydrofuran, dioxane, and ethylene glycol monomethyl ether. Further, the above reaction is advantageously carried out using a drying agent such as anhydrous calcium chloride, anhydrous copper sulfate, oil-water calcium sulfate, or phosphorus pentoxide. In the above esterification reaction, the proportions of the compounds represented by the general formulas [1-1] and [■] are not particularly limited and can be selected as appropriate; When using a solvent, the latter should be equimolar to the former.
It is desirable to use about 5 times the molar amount, preferably about the same molar to 2 times the molar amount. The reaction temperature is not particularly limited, but is usually -20
A temperature of about 0 to 200°C, preferably about 0 to 150°C can be adopted. The compound of the present invention represented by the general formula [1-2] is produced as described above.
かくして得られる本発明化合物は反応終了後常法に従つ
て反応混合物から単離される。例えば溶媒を用いた場合
は之を留去するかあるいは水、石油エーテル、エーテル
、n−ヘキサン等て稀釈もしくは抽出することにより得
られる。得られた化合物は必要に応じて再結晶法、溶媒
抽出法、カラムクロマトグフフイー、薄層クロマトグフ
フイー等の通常の方法により更に精製をすることができ
る。以下に参考例及び実施例を掲げて本発明をよソー層
明らかにする。After completion of the reaction, the compound of the present invention thus obtained is isolated from the reaction mixture according to a conventional method. For example, when a solvent is used, it can be obtained by distilling it off, or by diluting or extracting with water, petroleum ether, ether, n-hexane, etc. The obtained compound can be further purified, if necessary, by conventional methods such as recrystallization, solvent extraction, column chromatography, and thin layer chromatography. The present invention will be clearly explained by reference examples and examples below.
参考例
酢酸100mtに6−アセチルー3・4−ジヒドロカル
ボスチリル15.1yを加えて溶解させ内温35〜40
℃に保ちつつ、Br2ll.2mlを含む酢酸10m1
溶液を3.時間を要して攪拌下滴下する。Reference Example 15.1y of 6-acetyl-3,4-dihydrocarbostyryl was added to 100mt of acetic acid and dissolved, and the internal temperature was 35-40.
While keeping at ℃, Br2ll. 10ml of acetic acid containing 2ml
Add the solution to 3. It takes a while to be added dropwise while stirring.
反応液を一夜放置後析出晶を淵取し、少量の酢酸で洗浄
する。得られた結晶をエタノール溶媒にて活性炭処理を
し、エタノールから再結晶して炎黄色針状晶の6ージブ
ロモアセチルー3●4−ジヒドロカルボスチリル19.
5yを得る。融点168〜169.5得C実施例1
水250mLにNaOH26fを溶解させ90〜100
℃にて攪拌下6ージブロモアセチルー3・4−ジヒドロ
カルボスチリル35fを加えて3時間反応させる。After leaving the reaction solution overnight, the precipitated crystals are filtered out and washed with a small amount of acetic acid. The obtained crystals were treated with activated carbon in an ethanol solvent and recrystallized from ethanol to obtain 6-dibromoacetyl-3●4-dihydrocarbostyryl as flame yellow needle-like crystals.19.
Get 5y. Melting point 168-169.5 Obtained C Example 1 Dissolve 26f NaOH in 250 mL of water and
While stirring at °C, 35f of 6-dibromoacetyl-3,4-dihydrocarbostyryl was added and reacted for 3 hours.
冷後、不溶物を淵去し、母液を濃塩酸に酸性として析出
晶を枦取し水洗する。得られた結晶をエタノールから二
度再結晶して淡黄色不定形晶の6−カルボキシー3・4
−ジヒドロカルボスチリル10.5fを得る。融点32
4.5〜32rC(分解)
実施例2
実施例1と同様にして反応を行ない、6ージブロモアセ
チルカルボスチリルから無色針状晶の6−カルボキシカ
ルボスチリルを得る。After cooling, insoluble matter is filtered off, the mother liquor is acidified with concentrated hydrochloric acid, and the precipitated crystals are collected and washed with water. The obtained crystals were recrystallized twice from ethanol to give pale yellow amorphous crystals of 6-carboxy 3.4.
-dihydrocarbostyril 10.5f is obtained. Melting point 32
4.5-32rC (decomposition) Example 2 A reaction is carried out in the same manner as in Example 1 to obtain colorless needle-like 6-carboxycarbostyryl from 6-dibromoacetylcarbostyryl.
融点353〜35rC
実施例3
エタノール300mtに6−カルボキシー3●4−ジヒ
ドロカルボスチリル3.8y及び濃流酸0.5m1を加
えて還流を5時間行う。Melting point: 353-35rC Example 3 To 300 mt of ethanol, 3.8 y of 6-carboxy 3●4-dihydrocarbostyryl and 0.5 ml of concentrated acid were added and refluxed for 5 hours.
反応後、反応液を濃縮し、残にクロロホルム300m1
を加えて溶解させ、クロロホルム層を希NaHCO3水
、水で洗浄し、濃縮する。残をクロロホルムー石油エー
テルから再結晶して無色針状晶の6−エトキシカルボニ
ルー3・4−ジヒドロカルボスチリル3.1gを得る。
融点178〜179.5スC実施例4
実施例3と同様にして反応を行ない、6−カルボキシカ
ルボスチリルから無色針状晶の6−エトキシカルボニル
カルボスチリルを得る。After the reaction, concentrate the reaction solution and add 300ml of chloroform to the residue.
The chloroform layer is washed with dilute NaHCO3 water and water, and concentrated. The residue was recrystallized from chloroform-petroleum ether to obtain 3.1 g of 6-ethoxycarbonyl-3,4-dihydrocarbostyryl in the form of colorless needles.
Melting point: 178-179.5sC Example 4 A reaction is carried out in the same manner as in Example 3 to obtain colorless needle-like 6-ethoxycarbonylcarbostyryl from 6-carboxycarbostyryl.
融点230.5〜23rC
実施例5
デイーン・スタークの装置をつけた300Tntのコル
ベンに6−カルボキシー3●4−ジヒドロカルボスチリ
ル2.0y..p−トルエンスルホン酸1水塩4.5y
13−ピリジンメタノール1.3y及びベンゼン200
Tn1をとり還流下、攪拌を8時間行う。Melting point 230.5-23rC Example 5 6-carboxy 3●4-dihydrocarbostyryl 2.0y. .. p-Toluenesulfonic acid monohydrate 4.5y
13-pyridine methanol 1.3y and benzene 200
Take Tn1 and stir under reflux for 8 hours.
Claims (1)
キル基を、カルボスチリル骨格の3・4位の結合は一重
結合又は二重結合を夫々示す。 〕で表わされるカルボスチリル誘導体。[Claims] 1. General formula ▲ Numerical formula, chemical formula, table, etc. Double bonds are shown respectively. ] A carbostyryl derivative represented by
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9353377A JPS6043341B2 (en) | 1977-08-03 | 1977-08-03 | carbostyril derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9353377A JPS6043341B2 (en) | 1977-08-03 | 1977-08-03 | carbostyril derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5427574A JPS5427574A (en) | 1979-03-01 |
| JPS6043341B2 true JPS6043341B2 (en) | 1985-09-27 |
Family
ID=14084925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9353377A Expired JPS6043341B2 (en) | 1977-08-03 | 1977-08-03 | carbostyril derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6043341B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02117662A (en) * | 1989-09-01 | 1990-05-02 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
-
1977
- 1977-08-03 JP JP9353377A patent/JPS6043341B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5427574A (en) | 1979-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3998815A (en) | 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts | |
| PT98292A (en) | PROCESS FOR THE PREPARATION OF HETEROCYCLES, THIOXO AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| JPH0378390B2 (en) | ||
| JPS6043341B2 (en) | carbostyril derivatives | |
| IE911553A1 (en) | Azabenzimidazoles in the treatment of asthma, arthritis and¹related diseases | |
| PL123811B1 (en) | Process for preparing novel derivatives of pyran-4-one | |
| US4644071A (en) | Aralkoxy and aryloxyalkoxy kojic acid derivatives | |
| NO160442B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRAZOLO (1,5-A) PYRIDINE DERIVATIVES. | |
| US3156697A (en) | Pyridylcoumarins | |
| US4707473A (en) | 4-monosubstituted and 4,6-disubstituted phenoxazines | |
| US4160828A (en) | Analgesic phosphinyl compounds and compositions | |
| KR950014792B1 (en) | Benzimidazole derivatives and preparation method thereof | |
| US5330983A (en) | 14-O-p-chlorobenzoylaconine and analgesic/anti-inflammatory agent containing the same | |
| EP0191401B1 (en) | Novel antiallergic agents and process for their preparation | |
| JP3048698B2 (en) | Amidino-substituted aromatic compounds and salts thereof | |
| EP0026675B1 (en) | 1-azaxanthone-3-carboxylic acids, their preparation and pharmaceutical compositions containing them | |
| GB2030136A (en) | 1-phthalazone derivatives and acid addition salts their preparation and compositions containing them | |
| US5409952A (en) | Heterocyclic compounds: 2-styryl-4H-1-benzopyran-4-ones | |
| US4803269A (en) | 4-monosubstituted and 4,6-disubstituted N-(α-phenylethyl)phenoxazines | |
| JPS59176234A (en) | P-nitrophenyl-3-bromo-2,2-diethoxy-propionate | |
| US3436393A (en) | 4'-methoxy-2,2,4-trialkyl-delta**3-isoflavan compounds | |
| JPH0780812B2 (en) | Azulene derivative thromboxane synthetase inhibitor and process for producing the same | |
| Cornforth et al. | 22. Studies in the series of 4-substituted quinolines | |
| JPS5951941B2 (en) | carbostyril derivatives | |
| SU451246A3 (en) | The method of producing dibenzoxazepines |